Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
Details
Serval ID
serval:BIB_620D3186B3A0
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
Journal
International journal of public health
Working group(s)
Corona Immunitas Research Group
Contributor(s)
Albanese E., Amati R., Amendola A., Anker D., Annoni A.M., Azman A., Bally F., Balmer B., Baysson H., Berthod D., Blankenberger J., Bochud M., Bodenmann P., Bopp M., Butty A., Camerini A.L., Cappeli C., Carmelli C., Chiolero A., Collombet P., Corna L., Crawford J., Crivelli L., Cullati S., Cusini A., D'Acremont V., De Pietro C., Deschamps A., Droz S., Dumoulin A., Duperrex O., Dupraz J., Egger M., Engler N., Epure A.M., Estoppey S., Fadda M., Faivre V., Fehr J., Felappi A., Fiordelli M., Flahault A., Fornerod L., Fragoso Corti C., Frangville M., Frank I., Franscella G., Frei A., Gille D., Michel G., Gonseth Nusslé S., Gouzowski A., Guessous I., Guggisberg J., Günthard H., Gutzwiller F., Incici L., Jendly E., Jung R., Kahlert C., Kaiser L., Kaufmann L., Kaufmann M., Kessler S., Kohler P., Kriemler S., Lenoir L., Levati S., Maeschli B., Magnin J.L., Masserey E., Morese R., Mösli N., Noël N., Orhant M., Pasquier J., Pennacchio F., Petrovic D., Pfister S., Picazio A., Prandi C., Piumatti G., Portier J., Probst-Hensch N., Pugin C., Puhan M., Radtke T., Richard A., Robert C.F., Rodondi P.Y., Rodondi N., Salberg E., Sanchis Zozaya J., Schlüter V., Schneider V., Steiner-Dubuis A., Stringhini S., Sumer J., Tall I., Thabard J., Tonolla M., Troillet N., Ulyte A., Vassaux S., Vermes T., Vollrath F., von Wyl V., West E., Wisniak A., Zaballa M.E., Zuppinger C.
ISSN
1661-8564 (Electronic)
ISSN-L
1661-8556
Publication state
Published
Issued date
12/2020
Peer-reviewed
Oui
Volume
65
Number
9
Pages
1529-1548
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Seroprevalence studies to assess the spread of SARS-CoV-2 infection in the general population and subgroups are key for evaluating mitigation and vaccination policies and for understanding the spread of the disease both on the national level and for comparison with the international community.
Corona Immunitas is a research program of coordinated, population-based, seroprevalence studies implemented by Swiss School of Public Health (SSPH+). Over 28,340 participants, randomly selected and age-stratified, with some regional specificities will be included. Additional studies in vulnerable and highly exposed subpopulations are also planned. The studies will assess population immunological status during the pandemic.
Phase one (first wave of pandemic) estimates from Geneva showed a steady increase in seroprevalence up to 10.8% (95% CI 8.2-13.9, n = 775) by May 9, 2020. Since June, Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg recruited a total of 5973 participants for phase two thus far.
Corona Immunitas will generate reliable, comparable, and high-quality serological and epidemiological data with extensive coverage of Switzerland and of several subpopulations, informing health policies and decision making in both economic and societal sectors. ISRCTN Registry: https://www.isrctn.com/ISRCTN18181860 .
Corona Immunitas is a research program of coordinated, population-based, seroprevalence studies implemented by Swiss School of Public Health (SSPH+). Over 28,340 participants, randomly selected and age-stratified, with some regional specificities will be included. Additional studies in vulnerable and highly exposed subpopulations are also planned. The studies will assess population immunological status during the pandemic.
Phase one (first wave of pandemic) estimates from Geneva showed a steady increase in seroprevalence up to 10.8% (95% CI 8.2-13.9, n = 775) by May 9, 2020. Since June, Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg recruited a total of 5973 participants for phase two thus far.
Corona Immunitas will generate reliable, comparable, and high-quality serological and epidemiological data with extensive coverage of Switzerland and of several subpopulations, informing health policies and decision making in both economic and societal sectors. ISRCTN Registry: https://www.isrctn.com/ISRCTN18181860 .
Keywords
Adolescent, Adult, Aged, Antibodies, Viral/blood, Betacoronavirus/immunology, COVID-19/epidemiology, Child, Ethnic Groups, Humans, Middle Aged, Pandemics, Pneumonia, Viral/epidemiology, Research Design, SARS-CoV-2/isolation & purification, Seroepidemiologic Studies, Switzerland, Young Adult, Hygiene practices, Longitudinal, Prevalence, SARS-CoV-2, Serosurvey, Socioeconomic differences
Pubmed
Web of science
Open Access
Yes
Create date
02/11/2020 13:08
Last modification date
12/01/2022 7:10
Usage data
